GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +500.0% | 172 | +244.0% | 0.00% | – |
| Q2 2022 | $2,000 | +100.0% | 50 | +85.2% | 0.00% | – |
| Q1 2022 | $1,000 | -75.0% | 27 | -71.3% | 0.00% | -100.0% |
| Q1 2021 | $4,000 | -88.2% | 94 | -86.6% | 0.00% | -92.3% |
| Q3 2019 | $34,000 | +126.7% | 700 | +133.3% | 0.01% | +116.7% |
| Q2 2019 | $15,000 | -61.5% | 300 | -60.0% | 0.01% | -62.5% |
| Q1 2019 | $39,000 | -29.1% | 750 | -44.4% | 0.02% | -40.7% |
| Q4 2018 | $55,000 | – | 1,350 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |